Table 1.
Gene | Year of Discovery | Pathophysiology | Gene Type | Metabolomics | References |
---|---|---|---|---|---|
CSDE1 | 2016 | Tumor suppressor gene involved in mRNA stability and cellular apoptosis | Somatic | Adrenergic | [6,7] |
H3F3A | 2016 | Encodes histone H3.3 protein that regulates chromatin formation | Somatic | NA | [35,36] |
MET | 2016 | MAPK signaling pathway | Germline, somatic | NA | [23] |
MERTK | 2016 | Tyrosine kinase receptor | Germline | NA | [11,37,38] |
UBTF-MAML3 | 2017 | Unique methylation profile mRNA overexpression involved in Wnt receptor and hedgehog signaling pathways | Fusion | Adrenergic | [6,39] |
SLC25A11 | 2018 | Encodes malate-oxalate carrier protein of malate-aspartate shuttle | Germline | Noradrenergic | [40,41] |
IRP1 | 2018 | Cellular iron metabolism regulation | Somatic | noradrenergic | [42] |
DLST | 2019 | Encodes E2 subunit of mitochondrial α -KG complex which converts α-KG to succinyl-CoA | Germline | Noradrenergic | [23,43] |
SUCLG2 | 2021 | Catalyzes conversion of succinyl-coA and ADP/GTP to succinate and ATP/GTP | Germline | Noradrenergic | [44] |